Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102550 · ClinicalTrials.gov registry record · Phase 2
Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue
A Phase 2 study of Liver Transplant, sponsored by Choon Hyuck David Kwon.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07102550: Recruiting Phase 2 study of Liver Transplant, sponsored by Choon Hyuck David Kwon.
NCT07102550 is a Phase 2 study of Liver Transplant that is actively recruiting participants, run by Choon Hyuck David Kwon. The registered enrollment target is 40 participants, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07102550, a Phase 2 study of Liver Transplant, is actively recruiting participants, sponsored by Choon Hyuck David Kwon.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.
Primary Outcome
Biliary complications will be defined as any confirmed leakage of bile into the peritoneal cavity outside of the ductal system or biliary stricture.
Conditions Studied
Interventions
- BIOLOGICAL MiMedx AmnioFix
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2024-10-29 |
| Est. Completion | 2027-07 |
| Phase | Phase 2 |
What NCT07102550 shows while recruiting
NCT07102550 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 5,456-participant average among 19 other Liver Transplant trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Liver Transplant appearing as the primary indexed condition, and to 1 intervention - of which MiMedx AmnioFix is the first listed.
NCT07102550 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07102550 about?
NCT07102550 is a clinical study titled "Biliary Anastomosis in Living Donor Liver Transplant With Amniotic Tissue". The goal of this single armed, non-randomized, pilot study is to demonstrate that placental tissue grafts are safe in living donor liver transplant and assess their impact on biliary outcomes in adults.
What is the current status of trial NCT07102550?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 40 participants. The study started on 2024-10-29. Estimated completion is 2027-07.
What conditions does trial NCT07102550 study?
This clinical trial studies the following conditions: Liver Transplant.
What interventions are being tested in trial NCT07102550?
The interventions under investigation include: MiMedx AmnioFix (BIOLOGICAL).
Who is sponsoring clinical trial NCT07102550?
This trial is sponsored by Choon Hyuck David Kwon, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102550 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07102550's enrollment target sits among peer trials
40 16th of 19 higher than 3 of 19 other Liver Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
RECRUITING · Phase 2
-
Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates
RECRUITING · Phase 2
-
The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients
COMPLETED · Phase 2
-
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
COMPLETED · Phase 2
-
US National OCS Liver Perfusion (OLP) Registry
RECRUITING
-
Liver Transplant CGM
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI